ANI Pharmaceuticals (ANIP) vs Braveheart Bio (BRVE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ANI Pharmaceuticals is the larger company by market cap ($1.65 billion vs $1.64 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIP | BRVE |
|---|---|---|
| Share price | $71.84 | $18.19 |
| Market cap | $1.65B | $1.64B |
| 1-day change | -0.13% | -2.10% |
| YTD return | -8.88% | — |
| 1-year return | -21.54% | — |
| 5-year return | +86.64% | — |
| P/E ratio (TTM) | 15.55 | — |
| Forward P/E | 7.07 | — |
| EPS (TTM) | $4.62 | $-6.08 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $97.00 | $32.00 |
| 52-week low | $69.58 | $18.19 |
| Distance from 52-week high | -25.94% | -43.16% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +47.24% | +148.76% |
| Average volume | 372.56K | 562.23K |
| Shares outstanding | 22.96M | 90.04M |
| Employees | 970 | 49 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ANI Pharmaceuticals
ANIP stock →ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
Health Care · Biotechnology: Pharmaceutical Preparations · 970 employees
About Braveheart Bio
BRVE stock →Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees
ANIP vs BRVE FAQ
Which is bigger, ANI Pharmaceuticals or Braveheart Bio?
ANI Pharmaceuticals (ANIP) is larger, with a market capitalization of $1.65B compared with $1.64B for Braveheart Bio (BRVE).
Are ANI Pharmaceuticals and Braveheart Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.